|
Volumn 21, Issue 4 A, 2001, Pages 2585-2589
|
Synergistic enhancement of apoptosis by DNA- and cytoskeleton-damaging agents: A basis for combination chemotherapy of cancer
|
Author keywords
Actinomycin D; Apoptosis; Colcemid; Combination chemotherapy; Cytochalasin D; Mitomycin C; Vinblastine; VP 16
|
Indexed keywords
CASPASE 3;
CYTOCHALASIN D;
DACTINOMYCIN;
DEMECOLCINE;
ETOPOSIDE;
MITOMYCIN C;
VINBLASTINE;
APOPTOSIS;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CELL DEATH;
CONTROLLED STUDY;
DNA CLEAVAGE;
DRUG POTENTIATION;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
HELA CELL;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL LINE;
PRIORITY JOURNAL;
TUMOR CELL LINE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
CYTOCHALASIN D;
CYTOSKELETON;
DACTINOMYCIN;
DEMECOLCINE;
DNA DAMAGE;
DRUG SYNERGISM;
ETOPOSIDE;
HUMANS;
LEUKEMIA;
MITOMYCIN;
NEOPLASMS;
NUCLEIC ACID SYNTHESIS INHIBITORS;
TUMOR CELLS, CULTURED;
VINBLASTINE;
|
EID: 0035149526
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (17)
|
References (28)
|